Mutations in PRKAG2 are implicated in hypertrophic cardiomyopathy (PRKAG2 syndrome (Pöyhönen et al, 2015)) with a disease‐causing mutation (G100S) close to the predicted ULK target sites (Zhang et al, 2013). The gene discussed is PRKAG2; the disease is PRKAG2-related cardiomyopathy.